Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myr (MYRG) Cash & Equivalents (2016 - 2025)

Myr (MYRG) has disclosed Cash & Equivalents for 16 consecutive years, with $150.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 4234.76% to $150.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $150.2 million, a 4234.76% increase, with the full-year FY2025 number at $150.2 million, up 4234.76% from a year prior.
  • Cash & Equivalents was $150.2 million for Q4 2025 at Myr, up from $76.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $150.2 million in Q4 2025 to a low of $1.9 million in Q2 2024.
  • A 5-year average of $41.3 million and a median of $27.7 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 91.82% in 2024, then soared 4234.76% in 2025.
  • Myr's Cash & Equivalents stood at $82.1 million in 2021, then plummeted by 37.83% to $51.0 million in 2022, then plummeted by 51.22% to $24.9 million in 2023, then plummeted by 86.09% to $3.5 million in 2024, then skyrocketed by 4234.76% to $150.2 million in 2025.
  • Per Business Quant, the three most recent readings for MYRG's Cash & Equivalents are $150.2 million (Q4 2025), $76.2 million (Q3 2025), and $23.0 million (Q2 2025).